183 related articles for article (PubMed ID: 32651166)
1. Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated Macrophages.
Marigo I; Trovato R; Hofer F; Ingangi V; Desantis G; Leone K; De Sanctis F; Ugel S; Canè S; Simonelli A; Lamolinara A; Iezzi M; Fassan M; Rugge M; Boschi F; Borile G; Eisenhaure T; Sarkizova S; Lieb D; Hacohen N; Azzolin L; Piccolo S; Lawlor R; Scarpa A; Carbognin L; Bria E; Bicciato S; Murray PJ; Bronte V
Cancer Discov; 2020 Nov; 10(11):1758-1773. PubMed ID: 32651166
[TBL] [Abstract][Full Text] [Related]
2. Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.
Zhao X; Wang X; You Y; Wen D; Feng Z; Zhou Y; Que K; Gong J; Liu Z
Exp Cell Res; 2020 Jun; 391(1):111979. PubMed ID: 32246992
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.
Hannigan A; Smith P; Kalna G; Lo Nigro C; Orange C; O'Brien DI; Shah R; Syed N; Spender LC; Herrera B; Thurlow JK; Lattanzio L; Monteverde M; Maurer ME; Buffa FM; Mann J; Chu DC; West CM; Patridge M; Oien KA; Cooper JA; Frame MC; Harris AL; Hiller L; Nicholson LJ; Gasco M; Crook T; Inman GJ
J Clin Invest; 2010 Aug; 120(8):2842-57. PubMed ID: 20592473
[TBL] [Abstract][Full Text] [Related]
4. Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinoma.
Wang WL; Chang WL; Yang HB; Wang YC; Chang IW; Lee CT; Chang CY; Lin JT; Sheu BS
Oncotarget; 2016 Nov; 7(44):71169-71181. PubMed ID: 27036032
[TBL] [Abstract][Full Text] [Related]
5. Disabled-2 (
Price ZK; Lokman NA; Yoshihara M; Kajiyama H; Oehler MK; Ricciardelli C
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614139
[TBL] [Abstract][Full Text] [Related]
6. Disabled homolog 2 is required for migration and invasion of prostate cancer cells.
Xie Y; Zhang Y; Jiang L; Zhang M; Chen Z; Liu D; Huang Q
Front Med; 2015 Sep; 9(3):312-21. PubMed ID: 26143155
[TBL] [Abstract][Full Text] [Related]
7. Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation.
Adamson SE; Griffiths R; Moravec R; Senthivinayagam S; Montgomery G; Chen W; Han J; Sharma PR; Mullins GR; Gorski SA; Cooper JA; Kadl A; Enfield K; Braciale TJ; Harris TE; Leitinger N
J Clin Invest; 2016 Apr; 126(4):1311-22. PubMed ID: 26927671
[TBL] [Abstract][Full Text] [Related]
8. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
Du L; Zhao Z; Ma X; Hsiao TH; Chen Y; Young E; Suraokar M; Wistuba I; Minna JD; Pertsemlidis A
Oncogene; 2014 Aug; 33(34):4307-15. PubMed ID: 24037530
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Disabled-2 on skin fibrosis in systemic sclerosis.
Mei X; Zhao H; Huang Y; Tang Y; Shi X; Pu W; Jiang S; Ma Y; Zhang Y; Bai L; Tu W; Zhao Y; Jin L; Wu W; Wang J; Liu Q
J Dermatol Sci; 2020 Jul; 99(1):44-52. PubMed ID: 32571632
[TBL] [Abstract][Full Text] [Related]
10. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.
Xu XX; Yi T; Tang B; Lambeth JD
Oncogene; 1998 Mar; 16(12):1561-9. PubMed ID: 9569023
[TBL] [Abstract][Full Text] [Related]
11. Loss of Disabled-2 Expression in Pancreatic Cancer Progression.
Hocevar BA
Sci Rep; 2019 May; 9(1):7532. PubMed ID: 31101868
[TBL] [Abstract][Full Text] [Related]
12. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
13. MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression.
Yang K; Li YW; Gao ZY; Xiao W; Li TQ; Song W; Zheng J; Chen H; Chen GH; Zou HY
Int J Biol Macromol; 2019 Mar; 125():557-565. PubMed ID: 30543885
[TBL] [Abstract][Full Text] [Related]
14. Paracrine Signaling from Breast Cancer Cells Causes Activation of ID4 Expression in Tumor-Associated Macrophages.
Donzelli S; Sacconi A; Turco C; Gallo E; Milano E; Iosue I; Blandino G; Fazi F; Fontemaggi G
Cells; 2020 Feb; 9(2):. PubMed ID: 32054109
[TBL] [Abstract][Full Text] [Related]
15. Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT).
Prunier C; Howe PH
J Biol Chem; 2005 Apr; 280(17):17540-8. PubMed ID: 15734730
[TBL] [Abstract][Full Text] [Related]
16. Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells.
Sheng Z; Sun W; Smith E; Cohen C; Sheng Z; Xu XX
Oncogene; 2000 Oct; 19(42):4847-54. PubMed ID: 11039902
[TBL] [Abstract][Full Text] [Related]
17. The gene encoding the mitogen-responsive phosphoprotein Dab2 is differentially regulated by GATA-6 and GATA-4 in the visceral endoderm.
Morrisey EE; Musco S; Chen MY; Lu MM; Leiden JM; Parmacek MS
J Biol Chem; 2000 Jun; 275(26):19949-54. PubMed ID: 10779506
[TBL] [Abstract][Full Text] [Related]
18. [Effects of miR-145 on the migration and invasion of prostate cancer PC3 cells by targeting DAB2].
Xie S; Xie Y; Zhang Y; Huang Q
Yi Chuan; 2014 Jan; 36(1):50-7. PubMed ID: 24846918
[TBL] [Abstract][Full Text] [Related]
19. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
[TBL] [Abstract][Full Text] [Related]
20. Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis.
Jokubaitis VG; Gresle MM; Kemper DA; Doherty W; Perreau VM; Cipriani TL; Jonas A; Shaw G; Kuhlmann T; Kilpatrick TJ; Butzkueven H
Acta Neuropathol Commun; 2013 Jul; 1():32. PubMed ID: 24252604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
